<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04610294</url>
  </required_header>
  <id_info>
    <org_study_id>20-656</org_study_id>
    <nct_id>NCT04610294</nct_id>
  </id_info>
  <brief_title>Operating Room Air Filtration/Sterilization</brief_title>
  <official_title>Operating Room Air Filtration/Sterilization and Surgical Site Infection: A Randomized Multiple Cross-over Cluster Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Cleveland Clinic</source>
  <oversight_info>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Determine whether operating room air filtration and sterilization with the Aerus system&#xD;
      reduces a composite of serious surgical site infections, infection-related complications, and&#xD;
      death within 30 days after surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators primary goal is thus to determine whether filtering and sterilizing&#xD;
      operating room air reduces a composite of serious surgical site infections, infection-related&#xD;
      complications, and death within 30 days after surgery. The investigators will determine the&#xD;
      effect of air filtration and sterilization on serious surgical site infections, and on the&#xD;
      cost of care. infections, and on the cost of care.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2021</start_date>
  <completion_date type="Anticipated">June 2024</completion_date>
  <primary_completion_date type="Anticipated">January 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Crossover</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Composite outcome of postoperative complications</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>A composite of mortality, major surgical site infection, and healing-related wound complications</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Serious surgical site infection</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>Deep or organ-space surgical site infection will be evaluated by analysis of International Classification of Disease revision 10 (ICD-10) diagnosis codes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost-of-care</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>Our economic analysis will estimate the cost-effectiveness ratio, defined as the difference in average total hospital costs divided by the difference in the proportion with any of the components of the composite, and expressed as average cost per 1 percent improvement in the composite outcome.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">86639</enrollment>
  <condition>Non-cardiac Surgery</condition>
  <arm_group>
    <arm_group_label>Aerus air sterilization</arm_group_label>
    <description>Aerus air sterilization system will be used in an operating room, in addition to routine room air filtration</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional air handling</arm_group_label>
    <description>Only routine room air filtration will be used in an operation room.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Functioning Aerus air filtration/sterilization</intervention_name>
    <description>Two units of Aerus air sterilization system will be used in each operating room, and each will be set to &quot;high.&quot; Units used for the trial will be modified internally to be active and will be sealed to prevent operating room personnel from opening the system and determining a unit's status.</description>
    <arm_group_label>Aerus air sterilization</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Deactivated Aerus air filtration/sterilization</intervention_name>
    <description>Two units of Aerus air sterilization system will be used in each operating room, and each will be set to &quot;high.&quot; Units used for the trial will be modified internally to be inactivated and will be sealed to prevent operating room personnel from opening the system and determining a unit's status. Units will be inactivated by removing the activated carbon, high-efficiency particulate filter, and ionization chamber. However, the fan will remain active as will the &quot;run&quot; lights.</description>
    <arm_group_label>Conventional air handling</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The trial will take place in the adult operating rooms of the Cleveland Clinic Main Campus,&#xD;
        specifically ORs 1-25 in E and 28-38 in H, 40-50 in G, and J operating rooms. Because of&#xD;
        the cohort design, all patients who have surgery in these operating rooms will be included.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All patients in designated adult operating rooms&#xD;
&#xD;
          -  American Society of Anesthesiologists physical status 1-4.&#xD;
&#xD;
          -  Surgery lasting at least 1 hour.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients with present-on-admission infections&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniel I Sessler, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Roberta Johnson</last_name>
    <phone>216-444-9950</phone>
    <email>johnsor13@ccf.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mauro Bravo, MD</last_name>
    <phone>216-636-9449</phone>
    <email>bravom2@ccf.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roberta Johnson</last_name>
      <phone>216-444-9950</phone>
      <email>johnsor13@ccf.org</email>
    </contact>
    <contact_backup>
      <last_name>Mauro Bravo, MD</last_name>
      <phone>216-636-9449</phone>
      <email>bravom2@ccf.org</email>
    </contact_backup>
    <investigator>
      <last_name>Daniel I Sessler, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>October 26, 2020</study_first_submitted>
  <study_first_submitted_qc>October 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 30, 2020</study_first_posted>
  <last_update_submitted>July 9, 2021</last_update_submitted>
  <last_update_submitted_qc>July 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

